Of Course 23andMe's Plan Has Been to Sell Your Genetic Data All Along

Today, 23andMe announced what Forbes reports is only the first of ten deals with big biotech companies: Genentech will pay up to $60 million for access to 23andMe's data to study Parkinson's. You think 23andMe was about selling fun DNA spit tests for $99 a pop? Nope, it's been about selling your data all along. »1/06/15 3:35pm1/06/15 3:35pm

Why Genetic Testing Is So Important For Sports

Fast Company has a profile on 23andMe, the de facto public face of genetic testing, that's worth a read just for the look at the underpinnings of the science. But there's a moment in there that teases out the gut punch that can come from that knowledge, and that's closely related to how genetic testing in sports might… »10/16/13 5:12pm10/16/13 5:12pm

It Now Only Costs $100 To Know Everything About Your DNA

Mapping out your genome is the 21st Century equivalent of staring deep inside your soul; it's tempting to look, but terrifying what you might find. The DNA divers at 23andMe are hoping that slashing the price of their home-testing service—from $300 down to $100—will be enough to tilt the scales towards discovery. Are… »12/13/12 8:58am12/13/12 8:58am